InsidersTradesSigma
Gufic Biosciences Limited Stock: price and directors' dealings · India · SEBI (PIT + SAST)
Follow the Gufic Biosciences Limited stock price and the full insider trade history of the company, a publicly traded company based in India. Shares are listed on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Gufic Biosciences Limited has logged 7 public disclosures. Market capitalisation: €33.7bn. The latest transaction was filed on 3 June 2022 (Sale). Among the most active insiders: JAYESH CHOKSI. Every trade is free.
7
Insider Decl.
0
Thresholds
€215,153
3 ops.
Buy Volume
€1m
4 ops.
Sell Volume
10Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 15,539 of 25,927 companies
45.8
score / 100
Value32
Quality59
FCF yld0.4%
Earn yld1.7%
EV/EBITDA27.5x
ROE10%
Gross mgn55%
Net mgn6.8%
Debt/EBITDA2.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 June 2022
Declarations7 total
18,000 shares@ ₹220.42533.9% of flowEquity SharesSEBI:493695d46546f678999d809a50b941f94ffbb779
450,000 shares@ ₹217.646596.1% of flowEquity SharesSEBI:51ad21351354d733ab586d3740b62710c4644ab7
●
Executives
0Equity SharesSEBI:c6c85b7863ec453db354b785b9352eed00d4ad6b
0Equity SharesSEBI:4e582a9b8c45cd482639310bb2e118b3ea2ba64d
7,148,570 shares@ ₹1.000.0002% mcap100.0% of flowEquity SharesSEBI:d58e6e029c9f547b5f7200d1b4400cf24002bdf2
Ideal exit: 4 Mar 2022 (T+270)
7,148,570 shares@ ₹1.000.0002% mcap100.0% of flowEquity SharesSEBI:ba718e123ca1ed7b745f51e878396c06e735a158
Ideal exit: 4 Mar 2022 (T+270)
4,817,366 shares@ ₹1.000.0002% mcap100.0% of flowEquity SharesSEBI:e24b652c77ee490507ab93106f57c1f4de656bda
Ideal exit: 4 Mar 2022 (T+270)
7 of 7 declarations